Prof. Deraco started his professional career in 1989, as Associated Researcher at the Surgery Dept. and Experimental Oncology Dept. at the Fondazione IRCCS (National Cancer Institute) Milan, Italy, where he then became a part of the surgical team holding more roles: for over 10 years he had been the responsible doctor for Peritoneal Surface Malignancies Program, then, from 2017 he’s the director on Peritoneal Surface Malignancies Unit, and from 2015 he is also a Director of the ESPSO (European School of Peritoneal Surface Oncology). He also works as a Professor of Peritoneal Surface Malignancy, General Surgery, at the Milan University. Prof. Deraco is an expert of Cytoreducyive Surgery (CRS), Hiperthermic Intra Peritoneal Chemotherapy (HIPEC) and Pressurised Intra Peritoneal Aerosolized Chemotherapy (PIPAC), having treated, with these techniques, more than 1.200 patients with PSM.
Education
In 1987, Prof. Deraco graduated in Medicine and Surgery from the University of Messina, Italy with full marks, where 5 years later she specialized in General Surgery. In 1993 he obtained another specialization, in Oncology, from the Paris Dauphine University, France. In the years 1991-93 he obtained a 3-years research fellow supported by the Research Italian Ministry carried out at the Surgery Dept. at the "Gustave Roussy Institut" Villejuif, France and Surgery Dept. at "The Royal Marsden Hospital" London, UK. Then, in 1996, he spent a Fellowship of AIRC (Italian Association of Cancer Research) carried out at the Surgical Department of "Washington Cancer Institute” at the Washington Hospital Center, Washington DC, USA.
Research & Publications
Having held important academic positions throughout all the years his career, Prof. Deraco has always been actively engaged in the research, in the field of Peritoneal Surface Malignancy, Oncological Surgery. In 2013 he obtained the Italian National Scientific Habilitation as 1st and 2nd Level Professor of General Surgery. From 2010 to 2015 he taught Peritoneal Surface Malignancy at the Rome University Tor Vergata, School on Surgery of the Digestive Tract, from 2015 he works as a Professor of Peritoneal Surface Malignancy, General Surgery, at the Milan University. He taught Peritoneal Surface Malignancy Treatment Techniques for other several Italian and foreign institutions, where had also been an academic mentor for over 30 postdoctoral fellows from McGill University, Montreal, Canada; National Cancer Institute – ESE, Bogotá, Colombia; University Hospital Reina Sofia, Spain among others. He has published more than 250 indexed scientific articles and 25 book chapters with h-index = 53.
Prof. Deraco was engaged in scientific activity, as the executive member of the board of different scientific societies, such as SITILO (Italian Society for Loco Regional Cancer Therapy); GIM (Italian Mesothelioma Group); PSOGI (Peritoneal Surface Oncology International Group); IART (Italian Association for Rare Tumors); ESSO (European Society of Surgical Oncology) etc.
Prof. Deraco has been Scientific Director of many events including the PSOGI Consensus Conference in 2006 and Chair of the upcoming XIII PSOGI Congress (Venice October 2023). He is a member of the Steering Committee for the Italian AIOM guidelines and PSOGI guidelines on Peritoneal Surface Malignancies.
As Principal Investigator or Co-Investigator he has conducted multiple international and national research projects, eligible for funding on the basis of competitive calls for peer review. He is currently Principal or Co-Investigator of several research projects on Peritoneal Mesothelioma, Colorectal Cancer, Appendiceal Cancer and Pseudomixoma Peritonei, one of which is international (Accelerator Award).
Read moreProf. Deraco started his professional career in 1989, as Associated Researcher at the Surgery Dept. and Experimental Oncology Dept. at the Fondazione IRCCS (National Cancer Institute) Milan, Italy, where he then became a part of the surgical team holding more roles: for over 10 years he had been the responsible doctor for Peritoneal Surface Malignancies Program, then, from 2017 he’s the director on Peritoneal Surface Malignancies Unit, and from 2015 he is also a Director of the ESPSO (European School of Peritoneal Surface Oncology). He also works as a Professor of Peritoneal Surface Malignancy, General Surgery, at the Milan University. Prof. Deraco is an expert of Cytoreducyive Surgery (CRS), Hiperthermic Intra Peritoneal Chemotherapy (HIPEC) and Pressurised Intra Peritoneal Aerosolized Chemotherapy (PIPAC), having treated, with these techniques, more than 1.200 patients with PSM.
Education
In 1987, Prof. Deraco graduated in Medicine and Surgery from the University of Messina, Italy with full marks, where 5 years later she specialized in General Surgery. In 1993 he obtained another specialization, in Oncology, from the Paris Dauphine University, France. In the years 1991-93 he obtained a 3-years research fellow supported by the Research Italian Ministry carried out at the Surgery Dept. at the "Gustave Roussy Institut" Villejuif, France and Surgery Dept. at "The Royal Marsden Hospital" London, UK. Then, in 1996, he spent a Fellowship of AIRC (Italian Association of Cancer Research) carried out at the Surgical Department of "Washington Cancer Institute” at the Washington Hospital Center, Washington DC, USA.
Research & Publications
Having held important academic positions throughout all the years his career, Prof. Deraco has always been actively engaged in the research, in the field of Peritoneal Surface Malignancy, Oncological Surgery. In 2013 he obtained the Italian National Scientific Habilitation as 1st and 2nd Level Professor of General Surgery. From 2010 to 2015 he taught Peritoneal Surface Malignancy at the Rome University Tor Vergata, School on Surgery of the Digestive Tract, from 2015 he works as a Professor of Peritoneal Surface Malignancy, General Surgery, at the Milan University. He taught Peritoneal Surface Malignancy Treatment Techniques for other several Italian and foreign institutions, where had also been an academic mentor for over 30 postdoctoral fellows from McGill University, Montreal, Canada; National Cancer Institute – ESE, Bogotá, Colombia; University Hospital Reina Sofia, Spain among others. He has published more than 250 indexed scientific articles and 25 book chapters with h-index = 53.
Prof. Deraco was engaged in scientific activity, as the executive member of the board of different scientific societies, such as SITILO (Italian Society for Loco Regional Cancer Therapy); GIM (Italian Mesothelioma Group); PSOGI (Peritoneal Surface Oncology International Group); IART (Italian Association for Rare Tumors); ESSO (European Society of Surgical Oncology) etc.
Prof. Deraco has been Scientific Director of many events including the PSOGI Consensus Conference in 2006 and Chair of the upcoming XIII PSOGI Congress (Venice October 2023). He is a member of the Steering Committee for the Italian AIOM guidelines and PSOGI guidelines on Peritoneal Surface Malignancies.
As Principal Investigator or Co-Investigator he has conducted multiple international and national research projects, eligible for funding on the basis of competitive calls for peer review. He is currently Principal or Co-Investigator of several research projects on Peritoneal Mesothelioma, Colorectal Cancer, Appendiceal Cancer and Pseudomixoma Peritonei, one of which is international (Accelerator Award).
Bookimed, a leading global medical tourism platform, is committed to helping clients looking for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) by offering expert assistance and trustworthy medical solutions for every situation. Smart automatic ranking system is used to compose transparent clinic listings, meticulously maintained by a data scientist using AI for accuracy. The platform guarantees authenticity by publishing reviews from real patients after their treatments. Bookimed offers comprehensive medical solutions, with updates from clinics to ensure trustworthiness. The content about Hyperthermic Intraperitoneal Chemotherapy (HIPEC), crafted by experienced medical authors and reviewed by specialists, adheres to Bookimed"s Editorial Guidelines, reflecting the platform"s commitment to delivering high-quality and clear health information. For more details or inquiries, feel free to contact us at marketing@bookimed.com or learn more about us and our mission here.
Doctor Yesim Yildirim is an oncologist certified by the European Society of Medical Oncology (ESMO). Affiliated with numerous hospitals in the United States and Turkey, including the University of Maryland Medical Center, Johns Hopkins Hospital and Memorial Sisli Hospital. She has over 20 years of experience and has a special interest in preventive medicine, diabetes, and hypertension. Holds an MBA in Healthcare Management and shares her expertise with Bookimed from 2022.
The Medical Advisory Board expert is a verified credible medical professional with solid theoretical background and practical experience in the field. The expert provides support related to medical content accuracy for medical writers and performs educational workshops to Bookimed coordinators serving patient requests.
The medical content creation under the expert’s control follows rigorous and well-established procedure to be informative, trustworthy, and transparent and making Bookimed.com a credible source of evidence-based health information.